Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EPHB2 |
| Upstream (Parents) |
|---|
| (<<) ATIC → EPHB2 |
| (<<) BZW2 → EPHB2 |
| (<<) CEBPD → EPHB2 |
| (<<) CFL1 → EPHB2 |
| (<<) CHST7 → EPHB2 |
| (<<) NR3C1 → EPHB2 |
| (<<) PIK3C2B → EPHB2 |
| (<<) PLCG1 → EPHB2 |
| (<<) PTMA → EPHB2 |
| (<<) RAC1 → EPHB2 |
| (<<) RPIA → EPHB2 |
| (<<) RPL23A → EPHB2 |
| (<<) YWHAB → EPHB2 |
| Downstream (Children) |
|---|
| EPHB2 → ACTN4 (>>) |
| EPHB2 → ADCY3 (>>) |
| EPHB2 → ANKRD27 (>>) |
| EPHB2 → ARHGAP10 (>>) |
| EPHB2 → BAALC (>>) |
| EPHB2 → BCL6 (>>) |
| EPHB2 → BRCA1 (>>) |
| EPHB2 → CBFA2T3 (>>) |
| EPHB2 → ELF5 (>>) |
| EPHB2 → EPHB3 (>>) |
| EPHB2 → EREG (>>) |
| EPHB2 → ETS1 (>>) |
| EPHB2 → GPR153 (>>) |
| EPHB2 → HGS (>>) |
| EPHB2 → HIST3H3 (>>) |
| EPHB2 → ITGA6 (>>) |
| EPHB2 → ITPR3 (>>) |
| EPHB2 → LYPLA2 (>>) |
| EPHB2 → NBL1 (>>) |
| EPHB2 → NOTCH1 (>>) |
| EPHB2 → PIK3R2 (>>) |
| EPHB2 → PLA2G4C (>>) |
| EPHB2 → PLCB4 (>>) |
| EPHB2 → PLK1 (>>) |
| EPHB2 → PRKAB1 (>>) |
| EPHB2 → PTGS2 (>>) |
| EPHB2 → PTK7 (>>) |
| EPHB2 → RAB15 (>>) |
| EPHB2 → RND3 (>>) |
| EPHB2 → RNF11 (>>) |
| EPHB2 → ROCK1 (>>) |
| EPHB2 → RPS6KA1 (>>) |
| EPHB2 → SEMA3A (>>) |
| EPHB2 → SLC26A1 (>>) |
| EPHB2 → SLC6A14 (>>) |
| EPHB2 → SPPL2B (>>) |
| EPHB2 → ST3GAL1 (>>) |
| EPHB2 → UBE2D1 (>>) |
| EPHB2 → WWTR1 (>>) |
